title: Enhanced design of inhaled therapeutics: what does the future hold?
authors.affiliation: Novartis Pharmaceuticals Corporation, 150 Industrial Road, San Carlos, CA 94070, USA.
authors.forename: Jeffry G
authors.initials: JG
authors.lastname: Weers
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy; D015415:Biomarkers / Q000378:metabolism; D004337:Drug Carriers / Q000737:chemistry; D004339:Drug Compounding; D015195:Drug Design; D006801:Humans; D008168:Lung / Q000502:physiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D015415:Biomarkers; D004337:Drug Carriers
keywords: lung health; lung targeting; true adherence